MX9700552A - Conjugados de vitamina b12 y proteinas. - Google Patents
Conjugados de vitamina b12 y proteinas.Info
- Publication number
- MX9700552A MX9700552A MX9700552A MX9700552A MX9700552A MX 9700552 A MX9700552 A MX 9700552A MX 9700552 A MX9700552 A MX 9700552A MX 9700552 A MX9700552 A MX 9700552A MX 9700552 A MX9700552 A MX 9700552A
- Authority
- MX
- Mexico
- Prior art keywords
- vitamin
- administration
- conjugates
- proteins
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
- A61K47/551—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being a vitamin, e.g. niacinamide, vitamin B3, cobalamin, vitamin B12, folate, vitamin A or retinoic acid
Landscapes
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Se describen las proteínas terapéuticamente utiles que están conjugadas a la vitamina B12 mediante enlace covalente en el sitio del carboxilo primario de la porcion de ribosa. Los conjugados resultantes son biologicamente activos y pueden ser formulados en composiciones farmacéuticas apropiadas para la distribucion de diversas rutas de administracion, preferentemente oral. La captacion en el intestino después de la distribucion oral es además mejorada por la co-administracion del factor intrínseco purificado.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/282,384 US5574018A (en) | 1994-07-29 | 1994-07-29 | Conjugates of vitamin B12 and proteins |
PCT/US1995/009477 WO1996004016A1 (en) | 1994-07-29 | 1995-07-28 | Conjugates of vitamin b12 and proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9700552A true MX9700552A (es) | 1997-05-31 |
Family
ID=23081275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9700552A MX9700552A (es) | 1994-07-29 | 1995-07-28 | Conjugados de vitamina b12 y proteinas. |
Country Status (6)
Country | Link |
---|---|
US (1) | US5574018A (es) |
EP (1) | EP0774976A1 (es) |
JP (1) | JPH09508141A (es) |
CA (1) | CA2195566A1 (es) |
MX (1) | MX9700552A (es) |
WO (1) | WO1996004016A1 (es) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869465A (en) * | 1994-04-08 | 1999-02-09 | Receptagen Corporation | Methods of receptor modulation and uses therefor |
EP0754189B1 (en) * | 1994-04-08 | 2002-10-09 | Receptagen Corporation | Receptor modulating agents and methods relating thereto |
US6350730B1 (en) | 1994-08-17 | 2002-02-26 | The Rockefeller University | OB polypeptides and modified forms as modulators of body weight |
US6471956B1 (en) | 1994-08-17 | 2002-10-29 | The Rockefeller University | Ob polypeptides, modified forms and compositions thereto |
US6048837A (en) * | 1994-08-17 | 2000-04-11 | The Rockefeller University | OB polypeptides as modulators of body weight |
US6124448A (en) * | 1994-08-17 | 2000-09-26 | The Rockfeller University | Nucleic acid primers and probes for the mammalian OB gene |
US6429290B1 (en) | 1994-08-17 | 2002-08-06 | The Rockefeller University | OB polypeptides, modified forms and derivatives |
US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
US6001968A (en) | 1994-08-17 | 1999-12-14 | The Rockefeller University | OB polypeptides, modified forms and compositions |
US5739313A (en) | 1995-11-13 | 1998-04-14 | Regents Of The University Of Minnesota | Radionuclide labeling of vitamin B12 and coenzymes thereof |
PT1007533E (pt) | 1996-08-27 | 2005-09-30 | Univ Utah Res Found | Bioconjugados e administracao de agentes bioactivos |
AU2003204343B2 (en) * | 1998-06-12 | 2007-03-15 | Access Pharmaceuticals Australia Pty Limited | Vitamin B12 derivatives and methods for their preparation |
AUPP405098A0 (en) * | 1998-06-12 | 1998-07-02 | Access Pharmaceuticals Australia Pty Limited | Novel methods of preparation of vitamin b12 derivatives suitable for conjugation to pharmaceuticals |
US20010008627A1 (en) | 1999-01-22 | 2001-07-19 | Soll David R. | Hiv-encoded chemoattractant |
US6806363B1 (en) * | 1999-04-16 | 2004-10-19 | Mayo Foundation For Medical Education & Research | Cobalamin conjugates useful as antitumor agents |
KR20020059618A (ko) * | 1999-10-15 | 2002-07-13 | 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 | 이미지화제 및 항종양제로서 유용한 코발라민 콘쥬게이트 |
US7591995B2 (en) | 1999-10-15 | 2009-09-22 | Mayo Foundation For Medical Education And Research | Cobalamin conjugates useful as imaging and therapeutic agents |
EP1239887A1 (en) | 1999-10-15 | 2002-09-18 | Mayo Foundation For Medical Education And Research | Cobalamin conjugates useful as imaging and therapeutic agents |
ES2341843T3 (es) | 2000-02-03 | 2010-06-29 | EISAI R&D MANAGEMENT CO., LTD. | Inhibidores de la expresion de integrina. |
US20020042394A1 (en) * | 2000-05-31 | 2002-04-11 | Hogenkamp Henricus P.C. | Cobalamin compounds useful as antibiotic agents and as imaging agents |
AU6972901A (en) * | 2000-05-31 | 2001-12-11 | Mayo Foundation | Cobalamin compounds useful as cardiovascular agents and as imaging agents |
EP1754712A3 (en) * | 2000-10-25 | 2009-01-14 | Mayo Foundation For Medical Education And Research | Transcobalamin binding conjugates useful for treating abnormal cellular proliferation |
AU2002243438A1 (en) * | 2000-10-25 | 2002-07-24 | Mayo Foundation For Medical Education And Research | Transcobalamin binding conjugates useful for treating abnormal cellular proliferation |
GB2374010B (en) * | 2001-02-26 | 2004-12-29 | Council Scient Ind Res | Novel vitamin B12 - biodegradable micro particulate conjugate carrier systems for peroral delivery of drugs, therapeutic peptides/proteins and vaccines |
JP2005506957A (ja) | 2001-06-11 | 2005-03-10 | トランジション・セラピューティックス・インコーポレーテッド | ウイルス性、増殖性および炎症性の疾患の治療のためにビタミンb12およびインターフェロンを用いた複合治療 |
US20050175585A1 (en) * | 2001-06-11 | 2005-08-11 | Transition Therapeutics Inc. | Combination therapies using vitamin B12 and interferon for treatment of viral proliferative and inflammatory disesases |
US20030018009A1 (en) * | 2001-06-20 | 2003-01-23 | Collins Douglas A. | Adenosyl-cobalamin fortified compositions |
US20060074034A1 (en) * | 2001-09-17 | 2006-04-06 | Collins Douglas A | Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof |
WO2003026674A1 (en) * | 2001-09-28 | 2003-04-03 | Mayo Foundation For Medical Education And Research | Coadministration of transport protein with conjugated cobalamin to deliver agents |
WO2003030929A1 (en) * | 2001-10-05 | 2003-04-17 | Transition Therapeutics Inc. | Combination therapies using methyl donors or methyl donor enhancers and therapeutic agents for treatment of viral, proliferative and inflammatory diseases |
KR20040085205A (ko) * | 2002-02-20 | 2004-10-07 | 일라이 릴리 앤드 캄파니 | Glp-1 분자의 투여 방법 |
KR100440725B1 (ko) * | 2002-06-20 | 2004-07-15 | 주식회사 그린진 바이오텍 | 비생물성 스트레스에 대한 단자엽 식물의 내성을증가시키는 방법 |
US20040047917A1 (en) * | 2002-09-06 | 2004-03-11 | Stephen Wilson | Drug delivery and targeting with vitamin B12 conjugates |
EP2529758A3 (en) * | 2003-01-27 | 2013-01-02 | Endocyte, Inc. | Vitamin receptor binding drug delivery conjugates |
US7232805B2 (en) * | 2003-09-10 | 2007-06-19 | Inflabloc Pharmaceuticals, Inc. | Cobalamin conjugates for anti-tumor therapy |
US8883723B2 (en) * | 2007-03-05 | 2014-11-11 | Syracuse University | Conjugate of insulin and vitamin B12 for oral delivery |
US20110092416A1 (en) * | 2007-03-05 | 2011-04-21 | Robert Patrick Doyle | Vitamine B12 - Peptide Conjugates for Oral Delivery |
JP5690589B2 (ja) | 2007-06-25 | 2015-03-25 | エンドサイト・インコーポレイテッドEndocyte, Inc. | 親水性スペーサーリンカーを含有する結合体 |
US20100330161A1 (en) * | 2009-06-29 | 2010-12-30 | Syracuse University Technology Transfer And Industrial Development Office | Oral delivery of tetanus toxoid |
WO2011130716A2 (en) | 2010-04-16 | 2011-10-20 | Access Pharmaceuticals, Inc. | A nanostructures containing vitamin b12 for facilitated delivery of drugs across biological barriers |
EP2683410A2 (en) | 2011-03-08 | 2014-01-15 | Access Pharmaceuticals, Inc. | Targeted nanocarrier systems for delivery of actives across biological membranes |
US9120858B2 (en) | 2011-07-22 | 2015-09-01 | The Research Foundation Of State University Of New York | Antibodies to the B12-transcobalamin receptor |
US9289507B2 (en) | 2012-05-17 | 2016-03-22 | Extend Biosciences, Inc. | Carriers for improved drug delivery |
EP3036008A4 (en) * | 2013-08-22 | 2017-04-05 | Robert Doyle | Compositions comprising vitamin b12 and intrinsic factor and methods of use thereof |
US9585934B2 (en) | 2014-10-22 | 2017-03-07 | Extend Biosciences, Inc. | Therapeutic vitamin D conjugates |
US9616109B2 (en) | 2014-10-22 | 2017-04-11 | Extend Biosciences, Inc. | Insulin vitamin D conjugates |
US9789197B2 (en) | 2014-10-22 | 2017-10-17 | Extend Biosciences, Inc. | RNAi vitamin D conjugates |
US20180154007A1 (en) * | 2015-05-20 | 2018-06-07 | Syracuse University | Glycemic Control Using Intrinsic Factor Bound to A Vitamin B12 Conjugate of a Glucagon-Like Peptide-1 Receptor Agonist |
WO2016187512A1 (en) * | 2015-05-20 | 2016-11-24 | Syracuse University | Compositions and methods for enhancing peptide stability against protease digestion |
EP3432870A4 (en) * | 2016-03-22 | 2019-11-20 | Balchem Corporation | COMPOSITIONS WITH CHOLIN |
GB202018713D0 (en) | 2020-11-27 | 2021-01-13 | Quadram Inst Bioscience | Methods and compositions utilising vitamin b12 binding |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3981863A (en) * | 1975-02-25 | 1976-09-21 | Micromedic Diagonistics, Inc. | Cyanocobalamin derivatives |
NZ217821A (en) * | 1985-10-10 | 1989-07-27 | Biotech Australia Pty Ltd | Oral delivery system; complex of active agent and vitamin b12 or analogue thereof |
IL93982A0 (en) * | 1989-04-03 | 1991-01-31 | Purdue Research Foundation | Method for enhancing transmembrane transport of exogenous molecules |
JP3296817B2 (ja) * | 1991-04-02 | 2002-07-02 | バイオテック・オーストラリア・ピーティーワイ・リミテッド | 微粒子に適した経口配布系 |
CA2163225A1 (en) * | 1993-05-20 | 1994-12-08 | Gregory John Russell-Jones | Lhrh antagonists |
US5548064A (en) * | 1993-05-24 | 1996-08-20 | Biotech Australia Pty Limited | Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions |
US5449720A (en) * | 1993-05-24 | 1995-09-12 | Biotech Australia Pty Limited | Amplification of the VB12 uptake system using polymers |
-
1994
- 1994-07-29 US US08/282,384 patent/US5574018A/en not_active Expired - Lifetime
-
1995
- 1995-07-28 CA CA002195566A patent/CA2195566A1/en not_active Abandoned
- 1995-07-28 WO PCT/US1995/009477 patent/WO1996004016A1/en not_active Application Discontinuation
- 1995-07-28 MX MX9700552A patent/MX9700552A/es unknown
- 1995-07-28 EP EP95928153A patent/EP0774976A1/en not_active Withdrawn
- 1995-07-28 JP JP8506605A patent/JPH09508141A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2195566A1 (en) | 1996-02-15 |
AU3201595A (en) | 1996-03-04 |
US5574018A (en) | 1996-11-12 |
JPH09508141A (ja) | 1997-08-19 |
WO1996004016A1 (en) | 1996-02-15 |
AU683581B2 (en) | 1997-11-13 |
EP0774976A1 (en) | 1997-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9700552A (es) | Conjugados de vitamina b12 y proteinas. | |
IL139285A0 (en) | Peg-lhrh analog conjugates, their preparation and use | |
NO981436D0 (no) | Farmasöytiske angiostatiske dipeptidsammensetninger og anvendelse derav | |
GEP20053473B (en) | High Potency Dihydroergotamine Compositions | |
TR200002299T2 (tr) | Epotilon kompozisyonları. | |
AR008378A1 (es) | Conjudados de interferon | |
MX9700081A (es) | Composiciones farmaceuticas de tacrina. | |
PH24313A (en) | Emulsion composition for administration of sparingly water soluble ionizable hydrophobic drugs | |
TWI266800B (en) | Polyol-IFN-beta conjugates | |
FI890599A (fi) | Antracyklin-immunokonjugater med ny linker och foerfarande foer deras producering. | |
HRP20020787B1 (en) | Method of treatment using ligand-immunogen conjugates | |
MY118371A (en) | Tetrahydrolipstatin containing compositions | |
AU2874099A (en) | Low molecular weight compounds administered together with anti-cancer agents to treat cancer and pharmaceutical compositions thereof | |
GEP20022784B (en) | Celecoxib Composition | |
FR2762843B1 (fr) | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent | |
ATE198834T1 (de) | Konjugate bestehend aus polysaccharid und protein | |
HUT75513A (en) | Taxane class derivative based pharmaceutical compositions and their preparation | |
MXPA03011282A (es) | Mezclas de conjugados de farmaco de hormona de crecimiento-oligomero que comprenden polialquilenglicol, uso de los mismos y metodos para su elaboracion. | |
EE04606B1 (et) | H+, K+-ATPaasi inhibiitori kasutamine ravimi valmistamiseks peroraalseks manustamiseks | |
HUP0302635A2 (hu) | Valpronsav foszfolipidszármazékai és ezek keveréke | |
BR9611571B1 (pt) | composiÇço farmacÊutica estÁvel, kit para administraÇço de ngf e produto medicinal. | |
IL136733A0 (en) | Pharmaceutical composition containing sibutramine and orlistat | |
TR199900770T2 (xx) | Nazal poliplerin tedavisinde bir H+, K+-ATPase'�n kullan�lmas�. | |
CA2403721A1 (en) | Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor | |
ID23424A (id) | Glikokonjugat dari 20(s)-kamptotesin |